Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testicular Neoplasms | 10 | 2017 | 19 | 1.930 |
Why?
|
| Wilms Tumor | 7 | 2011 | 10 | 1.220 |
Why?
|
| Ureteral Obstruction | 7 | 2008 | 18 | 1.150 |
Why?
|
| Kidney Neoplasms | 7 | 2011 | 74 | 1.150 |
Why?
|
| Child | 32 | 2017 | 1211 | 1.040 |
Why?
|
| Ureter | 6 | 2008 | 26 | 0.980 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 5 | 2017 | 6 | 0.970 |
Why?
|
| Nephrectomy | 8 | 2011 | 37 | 0.950 |
Why?
|
| Urologists | 2 | 2016 | 3 | 0.680 |
Why?
|
| Child, Preschool | 19 | 2017 | 609 | 0.620 |
Why?
|
| Infant | 22 | 2017 | 520 | 0.620 |
Why?
|
| Hypospadias | 4 | 2010 | 4 | 0.600 |
Why?
|
| Urinary Fistula | 2 | 2008 | 3 | 0.580 |
Why?
|
| Kidney Pelvis | 4 | 2008 | 16 | 0.570 |
Why?
|
| Pediatricians | 1 | 2016 | 3 | 0.540 |
Why?
|
| Urology | 2 | 2015 | 17 | 0.530 |
Why?
|
| Health Care Surveys | 1 | 2016 | 58 | 0.530 |
Why?
|
| Attitude of Health Personnel | 2 | 2016 | 138 | 0.530 |
Why?
|
| Medical Oncology | 1 | 2016 | 37 | 0.530 |
Why?
|
| Orchiectomy | 2 | 2015 | 5 | 0.500 |
Why?
|
| Male | 41 | 2017 | 13815 | 0.500 |
Why?
|
| Physician's Role | 1 | 2015 | 17 | 0.490 |
Why?
|
| Urethra | 5 | 2010 | 14 | 0.490 |
Why?
|
| Urinary Bladder | 3 | 2006 | 17 | 0.480 |
Why?
|
| Vesico-Ureteral Reflux | 4 | 2001 | 5 | 0.480 |
Why?
|
| Humans | 49 | 2017 | 25165 | 0.470 |
Why?
|
| Kidney | 4 | 2006 | 145 | 0.460 |
Why?
|
| Laparoscopy | 4 | 2010 | 168 | 0.460 |
Why?
|
| Cystostomy | 3 | 2004 | 4 | 0.460 |
Why?
|
| Testicular Diseases | 2 | 2010 | 15 | 0.440 |
Why?
|
| Neoplasms | 1 | 2015 | 215 | 0.400 |
Why?
|
| Urologic Surgical Procedures, Male | 4 | 2010 | 23 | 0.400 |
Why?
|
| Cutaneous Fistula | 2 | 2010 | 3 | 0.400 |
Why?
|
| Cryptorchidism | 2 | 2010 | 3 | 0.390 |
Why?
|
| Ovarian Neoplasms | 3 | 2017 | 69 | 0.370 |
Why?
|
| Adolescent | 14 | 2017 | 2018 | 0.360 |
Why?
|
| Neoplasm Seeding | 1 | 2011 | 8 | 0.360 |
Why?
|
| Intraoperative Complications | 1 | 2011 | 60 | 0.350 |
Why?
|
| Hydronephrosis | 3 | 2008 | 6 | 0.340 |
Why?
|
| Lithiasis | 1 | 2010 | 2 | 0.340 |
Why?
|
| Infant, Newborn | 9 | 2017 | 572 | 0.320 |
Why?
|
| Preoperative Care | 1 | 2009 | 108 | 0.310 |
Why?
|
| Urethral Diseases | 1 | 2008 | 3 | 0.310 |
Why?
|
| Polyps | 1 | 2008 | 3 | 0.310 |
Why?
|
| Ureteral Neoplasms | 1 | 2008 | 7 | 0.300 |
Why?
|
| Prenatal Diagnosis | 1 | 2008 | 14 | 0.290 |
Why?
|
| Rectal Fistula | 1 | 2006 | 1 | 0.270 |
Why?
|
| Anal Canal | 1 | 2006 | 3 | 0.270 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 14 | 0.270 |
Why?
|
| Fetus | 1 | 2004 | 37 | 0.230 |
Why?
|
| Cystitis | 1 | 2004 | 12 | 0.230 |
Why?
|
| Eosinophilia | 1 | 2004 | 39 | 0.220 |
Why?
|
| Registries | 2 | 2002 | 173 | 0.200 |
Why?
|
| Female | 19 | 2017 | 14161 | 0.190 |
Why?
|
| Pediatrics | 2 | 2015 | 33 | 0.170 |
Why?
|
| Combined Modality Therapy | 3 | 2009 | 273 | 0.160 |
Why?
|
| Surgical Flaps | 2 | 2010 | 47 | 0.160 |
Why?
|
| Societies, Medical | 2 | 2016 | 113 | 0.160 |
Why?
|
| Pregnancy | 3 | 2008 | 298 | 0.160 |
Why?
|
| Lymphedema | 1 | 1998 | 4 | 0.150 |
Why?
|
| Urinary Tract Infections | 1 | 1999 | 30 | 0.150 |
Why?
|
| Testis | 3 | 2015 | 9 | 0.150 |
Why?
|
| Genital Diseases, Male | 1 | 1998 | 7 | 0.150 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1998 | 24 | 0.150 |
Why?
|
| Choristoma | 1 | 1998 | 5 | 0.150 |
Why?
|
| Gonadal Dysgenesis | 1 | 2017 | 1 | 0.150 |
Why?
|
| Christianity | 1 | 1997 | 6 | 0.150 |
Why?
|
| Religion and Medicine | 1 | 1997 | 24 | 0.140 |
Why?
|
| Testicular Hydrocele | 2 | 1999 | 6 | 0.140 |
Why?
|
| Urologic Surgical Procedures | 1 | 2016 | 11 | 0.140 |
Why?
|
| Surgical Oncology | 1 | 2016 | 5 | 0.140 |
Why?
|
| Neoplasm Staging | 4 | 2017 | 331 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 177 | 0.130 |
Why?
|
| Replantation | 1 | 1995 | 8 | 0.120 |
Why?
|
| Postoperative Complications | 5 | 2010 | 841 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2016 | 105 | 0.120 |
Why?
|
| United States | 2 | 2016 | 1928 | 0.120 |
Why?
|
| Adult | 12 | 2017 | 7259 | 0.120 |
Why?
|
| Data Collection | 1 | 2014 | 87 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 172 | 0.110 |
Why?
|
| Retrospective Studies | 4 | 2014 | 3185 | 0.100 |
Why?
|
| Epidermal Cyst | 1 | 1993 | 5 | 0.100 |
Why?
|
| Kidney Transplantation | 1 | 1994 | 105 | 0.100 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 2 | 2002 | 2 | 0.100 |
Why?
|
| Abdomen | 1 | 1992 | 8 | 0.100 |
Why?
|
| Scrotum | 1 | 1992 | 13 | 0.100 |
Why?
|
| Disease-Free Survival | 3 | 2017 | 142 | 0.100 |
Why?
|
| Penis | 3 | 2009 | 80 | 0.090 |
Why?
|
| Balanitis Xerotica Obliterans | 1 | 2010 | 1 | 0.090 |
Why?
|
| Urethral Stricture | 1 | 2010 | 7 | 0.090 |
Why?
|
| Risk Factors | 3 | 2017 | 2179 | 0.090 |
Why?
|
| Time Factors | 3 | 2008 | 1336 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2010 | 208 | 0.090 |
Why?
|
| Kidney Calices | 1 | 1990 | 1 | 0.090 |
Why?
|
| Treatment Outcome | 4 | 2015 | 3204 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2017 | 1618 | 0.080 |
Why?
|
| Circumcision, Male | 2 | 2000 | 6 | 0.080 |
Why?
|
| Endodermal Sinus Tumor | 2 | 2002 | 3 | 0.080 |
Why?
|
| Survival Rate | 2 | 2017 | 290 | 0.080 |
Why?
|
| Sexual Development | 1 | 2009 | 1 | 0.080 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2009 | 2 | 0.080 |
Why?
|
| Fertility | 1 | 2009 | 17 | 0.080 |
Why?
|
| Prevalence | 1 | 2010 | 428 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2011 | 578 | 0.080 |
Why?
|
| Age Factors | 2 | 2009 | 712 | 0.070 |
Why?
|
| Twins | 1 | 2008 | 7 | 0.070 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 8 | 0.070 |
Why?
|
| Follow-Up Studies | 5 | 2015 | 1672 | 0.070 |
Why?
|
| Young Adult | 2 | 2010 | 1813 | 0.070 |
Why?
|
| Prognosis | 2 | 2015 | 693 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2006 | 48 | 0.070 |
Why?
|
| Infant, Premature | 1 | 2008 | 182 | 0.070 |
Why?
|
| Disease Progression | 1 | 2008 | 634 | 0.060 |
Why?
|
| Multicystic Dysplastic Kidney | 1 | 2005 | 1 | 0.060 |
Why?
|
| alpha-Fetoproteins | 2 | 2002 | 3 | 0.060 |
Why?
|
| Papilloma | 1 | 2005 | 4 | 0.060 |
Why?
|
| Uterus | 1 | 2004 | 12 | 0.060 |
Why?
|
| Sheep | 1 | 2004 | 17 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2005 | 30 | 0.060 |
Why?
|
| Recurrence | 2 | 2010 | 274 | 0.060 |
Why?
|
| Middle Aged | 6 | 2016 | 8303 | 0.060 |
Why?
|
| Urinary Bladder Diseases | 1 | 2004 | 7 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2004 | 208 | 0.060 |
Why?
|
| Sertoli Cell Tumor | 1 | 2002 | 1 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 836 | 0.050 |
Why?
|
| Animals | 3 | 2009 | 3430 | 0.050 |
Why?
|
| Patient Education as Topic | 2 | 2002 | 122 | 0.050 |
Why?
|
| Sports | 1 | 2002 | 55 | 0.050 |
Why?
|
| Neoplasms, Second Primary | 1 | 2001 | 38 | 0.040 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 44 | 0.040 |
Why?
|
| Athletic Injuries | 1 | 2002 | 152 | 0.040 |
Why?
|
| Suture Techniques | 1 | 2001 | 142 | 0.040 |
Why?
|
| Aged | 4 | 2016 | 8448 | 0.040 |
Why?
|
| Algorithms | 1 | 2002 | 338 | 0.040 |
Why?
|
| Prune Belly Syndrome | 1 | 1999 | 1 | 0.040 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 1999 | 3 | 0.040 |
Why?
|
| Spermatozoa | 1 | 1999 | 7 | 0.040 |
Why?
|
| Infertility, Male | 1 | 1999 | 6 | 0.040 |
Why?
|
| Hernia, Inguinal | 1 | 1999 | 21 | 0.040 |
Why?
|
| Teaching Materials | 1 | 1999 | 8 | 0.040 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1999 | 4 | 0.040 |
Why?
|
| Vena Cava, Inferior | 1 | 1999 | 8 | 0.040 |
Why?
|
| Urography | 1 | 1998 | 2 | 0.040 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 1998 | 5 | 0.040 |
Why?
|
| Hemodilution | 1 | 1997 | 1 | 0.040 |
Why?
|
| Varicocele | 1 | 1997 | 3 | 0.040 |
Why?
|
| Hemostasis, Surgical | 1 | 1997 | 13 | 0.040 |
Why?
|
| Teratoma | 1 | 1997 | 4 | 0.040 |
Why?
|
| Stents | 1 | 1998 | 75 | 0.040 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1997 | 39 | 0.040 |
Why?
|
| Bleomycin | 1 | 2017 | 1 | 0.030 |
Why?
|
| Etoposide | 1 | 2017 | 23 | 0.030 |
Why?
|
| North America | 1 | 2016 | 39 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2000 | 308 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 140 | 0.030 |
Why?
|
| Cisplatin | 1 | 2017 | 50 | 0.030 |
Why?
|
| Certification | 1 | 2016 | 23 | 0.030 |
Why?
|
| Surgeons | 1 | 2016 | 79 | 0.030 |
Why?
|
| Watchful Waiting | 1 | 2015 | 8 | 0.030 |
Why?
|
| Graft Survival | 1 | 1994 | 81 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 1993 | 29 | 0.030 |
Why?
|
| Retroperitoneal Space | 1 | 1992 | 8 | 0.020 |
Why?
|
| Epidemiologic Studies | 1 | 2010 | 24 | 0.020 |
Why?
|
| Parabiosis | 1 | 1990 | 2 | 0.020 |
Why?
|
| Renal Artery Obstruction | 1 | 1990 | 3 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 1990 | 26 | 0.020 |
Why?
|
| Thrombosis | 1 | 1990 | 51 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 1998 | 4508 | 0.020 |
Why?
|
| Semen Analysis | 1 | 2009 | 1 | 0.020 |
Why?
|
| Sperm Count | 1 | 2009 | 3 | 0.020 |
Why?
|
| Epididymis | 1 | 2009 | 6 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2009 | 278 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 387 | 0.020 |
Why?
|
| Reoperation | 1 | 2010 | 847 | 0.020 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2005 | 2 | 0.020 |
Why?
|
| Colposcopy | 1 | 2005 | 2 | 0.010 |
Why?
|
| Electrocoagulation | 1 | 2005 | 10 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 1300 | 0.010 |
Why?
|
| Hemorrhage | 1 | 2005 | 76 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 318 | 0.010 |
Why?
|
| Risk | 1 | 2002 | 192 | 0.010 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2001 | 2 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 637 | 0.010 |
Why?
|
| Survivors | 1 | 2001 | 68 | 0.010 |
Why?
|
| Endoscopes | 1 | 2000 | 8 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 2000 | 10 | 0.010 |
Why?
|
| Suction | 1 | 1999 | 40 | 0.010 |
Why?
|
| Puberty | 1 | 1997 | 11 | 0.010 |
Why?
|
| Ligation | 1 | 1997 | 33 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1996 | 68 | 0.010 |
Why?
|
| Inulin | 1 | 1990 | 1 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 1990 | 6 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 1990 | 14 | 0.010 |
Why?
|
| Creatinine | 1 | 1990 | 40 | 0.010 |
Why?
|
| Glomerular Filtration Rate | 1 | 1990 | 38 | 0.010 |
Why?
|
| Rats | 1 | 1990 | 639 | 0.000 |
Why?
|